Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy

OBJECTIVE: To determine the clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy (DN). METHODS: Seventy-two patients who were admitted to our department of endocrinology in our hospital during January 2018 and June 2019 were randomly divided into a control...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Zhang, Jing, Hou, Ming-hui, Du, Wei-xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713209/
https://www.ncbi.nlm.nih.gov/pubmed/35035400
http://dx.doi.org/10.12669/pjms.38.1.4417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713209/
https://www.ncbi.nlm.nih.gov/pubmed/35035400
http://dx.doi.org/10.12669/pjms.38.1.4417

Ejemplares similares